Joel Sheinfeld
Overview
Explore the profile of Joel Sheinfeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
2084
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gleeson J, Knezevic A, Bromberg M, Patil S, Sheinfeld J, Carver B, et al.
J Clin Oncol
. 2025 Mar;
:JCO2500475.
PMID: 40085809
No abstract available.
2.
Matulewicz R, Sheinfeld J
J Urol
. 2025 Mar;
:101097JU0000000000004507.
PMID: 40084632
No abstract available.
3.
Baky F, Matulewicz R, Knezevic A, Hossain J, Williams B, Lee A, et al.
BJU Int
. 2025 Jan;
PMID: 39789892
No abstract available.
4.
Flores J, Henriquez I, Jue J, Benfante N, Sheinfeld J, Matulewicz R, et al.
Urology
. 2024 Dec;
PMID: 39674379
Objective: To evaluate outcomes of onco-testis sperm extraction (TESE) and to define potential predictors of successful surgical sperm retrieval (SSR). Methods: For this study, we examined all men (i) diagnosed...
5.
Baky F, Liso N, Williams B, Knezevic A, Funt S, Feldman D, et al.
Clin Genitourin Cancer
. 2024 Sep;
22(6):102217.
PMID: 39307609
Background: Patients who undergo primary retroperitoneal lymph node dissection (pRPLND) for early-stage testicular cancer and have no cancer (pN0) found in the retroperitoneum are believed to have an excellent prognosis....
6.
Matulewicz R, Baky F, Knezevic A, Sheinfeld J, Williams B, Kantor R, et al.
Eur Urol Open Sci
. 2024 Sep;
68:1-9.
PMID: 39257620
Background: MicroRNAs (miRNAs) show promise as blood-based tumor markers for germ cell tumors (GCTs), with miRNA-371-3p being the most studied. The marginal benefit of including other candidate miRNAs to aid...
7.
Baky F, Liso N, Williams B, Reuter V, Tickoo S, Feldman D, et al.
Urology
. 2024 Aug;
193:174-179.
PMID: 39128634
Objective: To review the presentation and long-term oncologic outcomes of patients with regressed ("burnt out") primary testicular germ cell tumors (GCT). Certain testicular GCT can present with complete regression of...
8.
Gleeson J, Knezevic A, Bromberg M, Patil S, Sheinfeld J, Carver B, et al.
J Clin Oncol
. 2024 Jul;
42(26):3130-3139.
PMID: 39028926
Purpose: Paclitaxel, ifosfamide, and cisplatin (TIP) is an established salvage regimen for germ cell tumors (GCT) on the basis of a phase II trial, but efficacy on a large patient...
9.
Matulewicz R, Benfante N, Funt S, Feldman D, Carver B, Doudt A, et al.
J Urol
. 2023 Sep;
211(1):80-89.
PMID: 37672753
Purpose: Primary surgical treatment with retroperitoneal lymph node dissection aims to accurately stage and treat patients with node-positive pure seminoma while avoiding long-term risks of chemotherapy or radiation, traditional standard-of-care...
10.
Matulewicz R, Fankhauser C, Sheinfeld J, Bagrodia A
Transl Androl Urol
. 2023 Jul;
12(6):1016-1022.
PMID: 37426604
Background And Objective: Surveillance is the preferred management strategy for most men with clinical stage I testicular cancer after orchiectomy. However, frequent office visits, imaging tests, and laboratory studies place...